HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-AUG-10 3AMA TITLE PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR JNJ- TITLE 2 7706621 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA, PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: UNP RESIDUES 6-25; COMPND 12 SYNONYM: PKI, PKI-ALPHA, CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 13 MUSCLE/BRAIN ISOFORM; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 OTHER_DETAILS: THE 5-24 PEPTIDE FRAGMENT OF PKI WAS SYNTHESIZED KEYWDS PKA, PROTEIN KINASE A, SURROGATE, JNJ-7706621, TRANSFERASE, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.PFLUG,T.M.DE OLIVEIRA,D.BOSSEMEYER,R.A.ENGH REVDAT 4 01-NOV-23 3AMA 1 REMARK SEQADV LINK REVDAT 3 07-DEC-11 3AMA 1 JRNL REVDAT 2 07-SEP-11 3AMA 1 KEYWDS REVDAT 1 03-AUG-11 3AMA 0 JRNL AUTH A.PFLUG,T.M.DE OLIVEIRA,D.BOSSEMEYER,R.A.ENGH JRNL TITL MUTANTS OF PROTEIN KINASE A THAT MIMIC THE ATP-BINDING SITE JRNL TITL 2 OF AURORA KINASE JRNL REF BIOCHEM.J. V. 440 85 2011 JRNL REFN ISSN 0264-6021 JRNL PMID 21774789 JRNL DOI 10.1042/BJ20110592 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 41690 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2205 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2632 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE SET COUNT : 155 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3002 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 227 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : 0.03000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.112 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.074 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.036 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3104 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4189 ; 1.146 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 362 ; 5.187 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 155 ;34.113 ;23.871 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 552 ;12.842 ;15.054 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.131 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 433 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2362 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1815 ; 0.529 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2917 ; 0.981 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1289 ; 1.576 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1272 ; 2.622 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 350 REMARK 3 ORIGIN FOR THE GROUP (A): -27.4970 1.5610 -3.1140 REMARK 3 T TENSOR REMARK 3 T11: 0.0182 T22: 0.0653 REMARK 3 T33: 0.0269 T12: -0.0225 REMARK 3 T13: 0.0055 T23: -0.0164 REMARK 3 L TENSOR REMARK 3 L11: 0.9285 L22: 1.8080 REMARK 3 L33: 1.6071 L12: -0.3027 REMARK 3 L13: 0.0881 L23: -0.4173 REMARK 3 S TENSOR REMARK 3 S11: -0.0054 S12: -0.0370 S13: 0.0077 REMARK 3 S21: 0.0592 S22: -0.0119 S23: 0.0641 REMARK 3 S31: 0.1339 S32: -0.1256 S33: 0.0172 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 5 B 24 REMARK 3 ORIGIN FOR THE GROUP (A): -13.5420 -0.7100 8.9450 REMARK 3 T TENSOR REMARK 3 T11: 0.0464 T22: 0.0717 REMARK 3 T33: 0.0491 T12: 0.0047 REMARK 3 T13: 0.0004 T23: -0.0154 REMARK 3 L TENSOR REMARK 3 L11: 3.2379 L22: 6.6931 REMARK 3 L33: 6.6219 L12: -2.1771 REMARK 3 L13: 3.2333 L23: -4.3761 REMARK 3 S TENSOR REMARK 3 S11: -0.0862 S12: 0.1983 S13: 0.2144 REMARK 3 S21: -0.2845 S22: -0.2353 S23: -0.2523 REMARK 3 S31: -0.0755 S32: 0.3789 S33: 0.3215 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3AMA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000029425. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91969 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43939 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 43.690 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : 0.06900 REMARK 200 FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1CDK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25MM TRIS-HCL, 25MM NACL, 1.5MM REMARK 280 OCTANOYL-N-METHYLGLUCAMIDE, 1MM (5-24)-PKI,12-20% (V/V) METHANOL, REMARK 280 2-METHYL 2,4-PENTANEDIOL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.21000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.22000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.36000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.22000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.21000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.36000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 320 REMARK 465 PRO A 321 REMARK 465 GLY A 322 REMARK 465 ASP A 323 REMARK 465 THR A 324 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG B 15 O HOH B 131 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 13 CG GLU A 13 CD 0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 6 50.68 -100.63 REMARK 500 ASP A 166 41.34 -146.68 REMARK 500 ASP A 184 95.43 72.12 REMARK 500 LEU A 273 49.12 -88.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR MOLECULE SKE CAN BE CALLED AS JNJ-7706621. IT WAS REMARK 600 PURCHASED FROM CALBIOCHEM (MERCK KGAA, DARMSTADT, GERMANY)' REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SKE A 351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF CAMP-DEPENDENT REMARK 800 PROTEIN KINASE INHIBITOR ALPHA REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3AMB RELATED DB: PDB REMARK 900 PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR VX- REMARK 900 680 DBREF 3AMA A 0 350 UNP P17612 KAPCA_HUMAN 1 351 DBREF 3AMA B 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQADV 3AMA ARG A 47 UNP P17612 LYS 48 ENGINEERED MUTATION SEQADV 3AMA GLN A 95 UNP P17612 LEU 96 ENGINEERED MUTATION SEQADV 3AMA LEU A 120 UNP P17612 MET 121 ENGINEERED MUTATION SEQADV 3AMA ALA A 123 UNP P17612 VAL 124 ENGINEERED MUTATION SEQADV 3AMA LYS A 181 UNP P17612 GLN 182 ENGINEERED MUTATION SEQADV 3AMA ALA A 183 UNP P17612 THR 184 ENGINEERED MUTATION SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE ARG THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE GLN GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL LEU GLU TYR ALA PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE LYS SEQRES 15 A 351 VAL ALA ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP MODRES 3AMA SEP A 10 SER PHOSPHOSERINE MODRES 3AMA TPO A 197 THR PHOSPHOTHREONINE MODRES 3AMA SEP A 338 SER PHOSPHOSERINE HET SEP A 10 10 HET TPO A 197 11 HET SEP A 338 10 HET SKE A 351 27 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM SKE 4-({5-AMINO-1-[(2,6-DIFLUOROPHENYL)CARBONYL]-1H-1,2,4- HETNAM 2 SKE TRIAZOL-3-YL}AMINO)BENZENESULFONAMIDE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 SKE C15 H12 F2 N6 O3 S FORMUL 4 HOH *227(H2 O) HELIX 1 1 GLY A 1 ALA A 6 1 6 HELIX 2 2 GLY A 9 SER A 32 1 24 HELIX 3 3 HIS A 39 ASP A 41 5 3 HELIX 4 4 LYS A 76 LEU A 82 1 7 HELIX 5 5 GLN A 84 VAL A 98 1 15 HELIX 6 6 GLU A 127 GLY A 136 1 10 HELIX 7 7 SER A 139 LEU A 160 1 22 HELIX 8 8 LYS A 168 GLU A 170 5 3 HELIX 9 9 THR A 201 LEU A 205 5 5 HELIX 10 10 ALA A 206 LEU A 211 1 6 HELIX 11 11 LYS A 217 GLY A 234 1 18 HELIX 12 12 GLN A 242 SER A 252 1 11 HELIX 13 13 SER A 262 LEU A 273 1 12 HELIX 14 14 VAL A 288 ASN A 293 1 6 HELIX 15 15 HIS A 294 ALA A 298 5 5 HELIX 16 16 ASP A 301 GLN A 307 1 7 HELIX 17 17 THR B 5 ALA B 12 1 8 SHEET 1 A 5 PHE A 43 THR A 51 0 SHEET 2 A 5 ARG A 56 HIS A 62 -1 O VAL A 57 N LEU A 49 SHEET 3 A 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 A 5 ASN A 115 GLU A 121 -1 O LEU A 120 N ALA A 70 SHEET 5 A 5 LEU A 106 LYS A 111 -1 N PHE A 110 O TYR A 117 SHEET 1 B 2 LEU A 162 ILE A 163 0 SHEET 2 B 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 C 2 LEU A 172 ILE A 174 0 SHEET 2 C 2 ILE A 180 VAL A 182 -1 O LYS A 181 N LEU A 173 LINK C GLY A 9 N SEP A 10 1555 1555 1.34 LINK C SEP A 10 N GLU A 11 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 CISPEP 1 LYS A 8 GLY A 9 0 3.93 SITE 1 AC1 14 LEU A 49 VAL A 57 ALA A 70 LEU A 120 SITE 2 AC1 14 GLU A 121 TYR A 122 ALA A 123 GLY A 126 SITE 3 AC1 14 LEU A 173 ALA A 183 PHE A 327 ASP A 328 SITE 4 AC1 14 HOH A 433 HOH A 474 SITE 1 AC2 59 SEP A 10 SER A 53 GLN A 84 GLU A 86 SITE 2 AC2 59 LEU A 89 ARG A 93 GLU A 127 PHE A 129 SITE 3 AC2 59 SER A 130 ARG A 133 LYS A 168 PRO A 169 SITE 4 AC2 59 GLU A 170 PHE A 187 LYS A 189 ARG A 190 SITE 5 AC2 59 VAL A 191 LYS A 192 LEU A 198 CYS A 199 SITE 6 AC2 59 GLY A 200 THR A 201 GLU A 203 GLU A 230 SITE 7 AC2 59 GLY A 234 TYR A 235 PRO A 236 PHE A 239 SITE 8 AC2 59 ALA A 240 ASP A 241 PRO A 243 ARG A 256 SITE 9 AC2 59 ASP A 328 GLU A 349 HOH A 356 HOH A 380 SITE 10 AC2 59 HOH A 391 HOH A 466 HOH A 488 HOH A 520 SITE 11 AC2 59 HOH A 525 HOH B 25 HOH B 26 HOH B 30 SITE 12 AC2 59 HOH B 32 HOH B 33 HOH B 38 HOH B 39 SITE 13 AC2 59 HOH B 60 HOH B 72 HOH B 81 HOH B 102 SITE 14 AC2 59 HOH B 131 HOH B 161 HOH B 168 HOH B 176 SITE 15 AC2 59 HOH B 202 HOH B 220 HOH B 221 CRYST1 72.420 74.720 80.440 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013808 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013383 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012432 0.00000